129 related articles for article (PubMed ID: 34812580)
1. The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P-Glycoprotein Substrate Digoxin in Healthy Volunteers.
Scheuenpflug J; Kropeit D; Erb-Zohar K; Theis JGW; Stobernack HP; McCormick D; Zimmermann H; Rübsamen-Schaeff H
Clin Pharmacol Drug Dev; 2022 Jan; 11(1):6-15. PubMed ID: 34812580
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Safety of Letermovir and Midazolam Coadministration in Healthy Subjects.
Kropeit D; McCormick D; Erb-Zohar K; Stobernack HP; Zimmermann H; Rübsamen-Schaeff H
Clin Pharmacol Drug Dev; 2022 Jan; 11(1):16-24. PubMed ID: 34714967
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
Marshall WL; McCrea JB; Macha S; Menzel K; Liu F; van Schanke A; de Haes JIU; Hussaini A; Jordan HR; Drexel M; Kantesaria BS; Tsai C; Cho CR; Hulskotte EGJ; Butterton JR; Iwamoto M
J Clin Pharmacol; 2018 Jul; 58(7):897-904. PubMed ID: 29578577
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single- and Multiple-Dose Administration in Healthy Japanese Subjects.
Asari K; Ishii M; Yoshitsugu H; Wakana A; Fancourt C; Yoon E; Furihata K; McCrea JB; Stoch SA; Iwamoto M
Clin Pharmacol Drug Dev; 2022 Aug; 11(8):938-948. PubMed ID: 35238179
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects.
Kropeit D; von Richter O; Stobernack HP; Rübsamen-Schaeff H; Zimmermann H
Clin Pharmacol Drug Dev; 2018 Jan; 7(1):9-21. PubMed ID: 28967706
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants.
Adedoyin A; Fancourt C; Menzel K; Zhao T; Tomek C; Panebianco D; McCrea JB; Stoch SA; Iwamoto M
Clin Pharmacol Drug Dev; 2021 Feb; 10(2):198-206. PubMed ID: 32700459
[TBL] [Abstract][Full Text] [Related]
7. Letermovir: First Global Approval.
Kim ES
Drugs; 2018 Jan; 78(1):147-152. PubMed ID: 29288370
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment.
Kropeit D; McCormick D; Erb-Zohar K; Moiseev VS; Kobalava ZD; Stobernack HP; Zimmermann H; Rübsamen-Schaeff H
Br J Clin Pharmacol; 2017 Dec; 83(12):2678-2686. PubMed ID: 28722153
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the inhibitory effects of itraconazole on letermovir.
McCrea JB; Menzel K; Fancourt C; Witter R; Zhao T; Robbins JA; Stoch SA; Iwamoto M
Br J Clin Pharmacol; 2023 Jul; 89(7):2122-2130. PubMed ID: 36717270
[TBL] [Abstract][Full Text] [Related]
10. Effect of green tea catechins on the pharmacokinetics of digoxin in humans.
Kim TE; Shin KH; Park JE; Kim MG; Yun YM; Choi DH; Kwon KJ; Lee J
Drug Des Devel Ther; 2018; 12():2139-2147. PubMed ID: 30022812
[TBL] [Abstract][Full Text] [Related]
11. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.
Chemaly RF; Ullmann AJ; Stoelben S; Richard MP; Bornhäuser M; Groth C; Einsele H; Silverman M; Mullane KM; Brown J; Nowak H; Kölling K; Stobernack HP; Lischka P; Zimmermann H; Rübsamen-Schaeff H; Champlin RE; Ehninger G;
N Engl J Med; 2014 May; 370(19):1781-9. PubMed ID: 24806159
[TBL] [Abstract][Full Text] [Related]
12. Drug-Drug Interaction of Letermovir and Atorvastatin in Healthy Participants.
McCrea JB; Menzel K; Adedoyin A; Cho CR; Fox-Bosetti S; Macha S; Zhao T; Liu F; Panebianco D; Stoch SA; Iwamoto M
Clin Pharmacol Drug Dev; 2022 Apr; 11(4):420-428. PubMed ID: 35157785
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients.
Groll AH; Schulte JH; Antmen AB; Fraser CJ; Teal VL; Haber B; Caro L; McCrea JB; Fancourt C; Patel M; Menzel K; Badshah C
Pediatr Infect Dis J; 2024 Mar; 43(3):203-208. PubMed ID: 38241643
[TBL] [Abstract][Full Text] [Related]
14. Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics.
Robbins JA; Menzel K; Lassman M; Zhao T; Fancourt C; Chu X; Mostoller K; Witter R; Marceau West R; Stoch SA; McCrea JB; Iwamoto M
Clin Pharmacol Ther; 2022 Mar; 111(3):664-675. PubMed ID: 34888851
[TBL] [Abstract][Full Text] [Related]
15. Exposure-Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation Recipients.
Prohn M; Cho CR; Viberg A; Dykstra K; Davis C; Sabato P; Stone J; Badshah C; Murata Y; Leavitt R; Fancourt C; Macha S
Clin Pharmacol Ther; 2022 Feb; 111(2):485-495. PubMed ID: 34674258
[TBL] [Abstract][Full Text] [Related]
16. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
Marty FM; Ljungman P; Chemaly RF; Maertens J; Dadwal SS; Duarte RF; Haider S; Ullmann AJ; Katayama Y; Brown J; Mullane KM; Boeckh M; Blumberg EA; Einsele H; Snydman DR; Kanda Y; DiNubile MJ; Teal VL; Wan H; Murata Y; Kartsonis NA; Leavitt RY; Badshah C
N Engl J Med; 2017 Dec; 377(25):2433-2444. PubMed ID: 29211658
[TBL] [Abstract][Full Text] [Related]
17. Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P-glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers.
Wang X; Zhang ZY; Arora S; Hughes L; Wang J; Powers D; Christensen J; Lu S; Kansra V
J Clin Pharmacol; 2018 Feb; 58(2):202-211. PubMed ID: 28906558
[TBL] [Abstract][Full Text] [Related]
18. Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients.
Cho JC; Le AD; Locke SC
Drugs Today (Barc); 2018 Jun; 54(6):361-368. PubMed ID: 29998227
[TBL] [Abstract][Full Text] [Related]
19. Effect of letermovir on levonorgestrel and ethinyl estradiol pharmacokinetics
.
Adedoyin A; Cho CR; Fox-Bosetti S; Macha S; Zhao T; Liu F; Panebianco D; O'Reilly TE; McCrea J; Stoch SA; Iwamoto M
Int J Clin Pharmacol Ther; 2019 Sep; 57(9):450-457. PubMed ID: 31232280
[TBL] [Abstract][Full Text] [Related]
20. Absorption, Metabolism, Distribution, and Excretion of Letermovir.
Menzel K; Kothare P; McCrea JB; Chu X; Kropeit D
Curr Drug Metab; 2021; 22(10):784-794. PubMed ID: 33622223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
